All lobbying filings

THORN RUN PARTNERS

THORN RUN PARTNERS filed a Q1 termination report for BRIDGEBIO PHARMA, INC. on March 13, 2025, reporting $30,000 in lobbying income.

Lobbying for BRIDGEBIO PHARMA, INC. · Pharmaceutical Manufacturer.

All filings by THORN RUN PARTNERS · Everything BRIDGEBIO PHARMA, INC. has reported

Filing · LD-2 quarterly report Q1 termination

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Mar 13, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

California

Representation ended

Mar 1, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 2

BEAU SCHUYLER

Previously held: Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre
JESSIE HOWE BRAIRTON

Previously held: Senior Legislative Asst/Legislative Asst, Rep. Lamar Smith; LC/Asst, Senate Special Aging Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to the treatment of rare diseases.

Medicare/Medicaid

Issues related to the treatment of rare diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.